Risk stratification of colon carcinogenesis through enhanced backscattering spectroscopy analysis of the uninvolved colonic mucosa

Clinical Cancer Research

Volumn 12, Issue 3 I, 2006, Pages 961-968

  Roy, Hemant K ^a,c   Kim, Young L ^b   Liu, Yang ^b   Wali, Ramesh K ^a   Goldberg, Michael J ^a   Turzhitsky, Vladimir ^b   Horwitz, Jonathan ^a   Backman, Vadim ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CANCER RISK; COLON CARCINOGENESIS; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; HUMAN TISSUE; INSTRUMENTATION; LIGHT SCATTERING; MOUSE; NEOPLASM; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SPECTROSCOPY; TECHNIQUE;

ANIMALS; AZOXYMETHANE; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EQUIPMENT DESIGN; FEMALE; HUMANS; LIGHT; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; RATS; RATS, INBRED F344; RISK FACTORS; SCATTERING, RADIATION; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS;

EID: 32944465538     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1605     Document Type: Article

References (32)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin 2005;55:10-30.
2. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-60.
3. Zack DL, DiBaise JK, Quigley EM, Roy HK. Colorectal cancer screening compliance by medicine residents: perceived and actual. Am J Gastroenterol 2001;96:3004-8.
4. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-27.
5. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
6. Fenlon HM, Nunes DP, Schroy PC, III, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med 1999;341:1496-503.
7. Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004;291:1713-9.
8. Roy HK, Wali RK, Kim YL, Liu Y, Goldberg M, Backman V. Four-dimensional elastic light-scattering fingerprints as preneoplastic markers in the rat model of colon carcinogenesis. Gastroenterology 2004;126:1071-81.
9. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
10. Lewis JD, Ng K, Hung KE, et al. Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med 2003;163:413-20.
11. Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339:1277-84.
12. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
13. Schoenfeld P, Shad J, Ormseth E, et al. Military Colorectal Cancer Screening Trials Group. Predictive value of diminutive colonic adenoma trial: the PREDICT trial. Clin Gastroenterol Hepatol 2003;1:195-201.
14. Chen LC, Hao CY, Chiu YC, et al. Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients. Cancer Res 2004;64:3694-700.
15. Cui H, Cruz-Correa M, Giardiello FM, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003;299:1753-5.
16. Backman V, Wallace MB, Perelman LT, et al. Detection of preinvasive cancer cells. Nature 2000;406:35-6.
17. Perelman LT, Backman V, Wallace, et al. Observation of periodic fine structure in reflectance from biological tissue: a new technique for measuring nuclear size distribution. Phys Rev Lett 1998;80:627-30.
18. Gurjar RS, Backman V, Perelman LT, et al. Imaging human epithelial properties with polarized light-scattering spectroscopy. Nat Med 2001;7:1245-8.
19. Kim YL, Liu Y, Turzhitsky VM, Roy HK, Wali RK, Backman V. Coherent backscattering spectroscopy. Opt Lett 2004;29:1906-8.
20. Kim YL, Liu Y, Wali RK, Roy HK, Backman V. Low-coherent backscattering spectroscopy for tissue characterization. Appl Opt 2005;44:366-77.
21. Kim YL, Liu Y, Turzhitsky VM, Wali RK, Roy HK, Backman V. Depth-resolved low-coherence enhanced backscattering. Opt Lett 2005;30:741-3.
22. Calabrese P, Tavare S, Shibata D. Pretumor progression: clonal evolution of human stem cell populations. Am J Pathol 2004;164:1337-46.
23. Wali RK, Roy HK, Kim YL, et al. Increased microvascular blood content is an early event in colon carcinogenesis. Gut 2005;54:654-60.
24. Born M, Wolf E. Principles of optics: electromagnetic theory of propagation, interference and diffraction of light. 7th ed. Cambridge (NY): Cambridge University Press; 1999. p. 572-80.
25. Roy HK, Kim YL, Wali RK, et al. Markers in preneoplastic intestinal mucosa: an accurate predictor of tumor risk in the MIN mouse. Cancer Epidemiol Biomarkers Prev 2005;14:1639-45.
26. Bernstein C, Bernstein H, Garewal H, et al. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 1999;59:2353-7.
27. Anti M, Marra G, Armelao F, et al. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 1993;34:525-30.
28. McGarrity TJ, Peiffer LP. Protein kinase C activity as a potential marker for colorectal neoplasia. Dig Dis Sci 1994;39:458-63.
29. Booth C, Brady G, Potten CS. Crowd control in the crypt. Nat Med 2002;8:1360-1.
30. Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut 2004;53:899-910.
31. Preston SL, Wong WM, Chan AO, et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003;63:3819-25.
32. Kim KM, Calabrese P, Tavare S, Shibata D. Enhanced stem cell survival in familial adenomatous polyposis. Am J Pathol 2004;164:1369-77.